No premedication was given. Ten patients each were anesthetized with: 1) N,O (50%) and 0.5 MAC sevoflurane (1%); 2) sevoflurane alone (2%); 3) N,O (60%) and 0.5 MAC isoflurane (0.6%); and, 4) isoflurane alone (1.2%). A forearm minus fingertip, skin temperature gradient 20°C was considered significant vasoconstriction; the esophageal temperature triggering vasoconstriction identified the threshold. Morphometric characteristics were comparable in each group. The threshold for vasoconstriction was 35.8 + 0.3"C in the patients given 50% N,O combined with 0.5 MAC sevoflurane, which was significantly greater than that in those given 1.0 MAC sevoflurane: 35.1 2 0.4"C. Similarly, the threshold for vasoconstriction was 35.9 + 0.3"C in the patients given 60% N,O combined with 0.5 MAC isoflurane, which was significantly greater than that in those given 1.0 MAC isoflurane: 35.0 + 0.5"C. We thus conclude that N,O impairs thermoregulation less than sevoflurane or isoflurane.
(Anesth Analg 1995;80:1212-6) I ntraoperative hypothermia is common, and causes potentially serious complications (l-7). The reduction in core temperature immediately after induction of general anesthesia results largely from anesthetic-induced inhibition of tonic thermoregulatory vasoconstriction (8 -1 l), and subsequent core-toperipheral redistribution of body heat (12). Heat loss exceeding metabolic heat production then typically continues to reduce body temperature for several additional hours (13). Finally, reemergence of thermoregulatory vasoconstriction (in patients becoming sufficiently hypothermic) moderates further core hypothermia by decreasing cutaneous heat loss (14) and constraining metabolic heat to the core thermal compartment (15).
All general anesthetics so far tested significantly decrease the thermoregulatory threshold for vasoconstiction (i.e., the core temperature triggering vasoconstriction) (8-11). Because vasoconstriction is effective in minimizing additional core hypothermia (15), anesthetic combinations causing less-than-typical thermoregulatory inhibition may be preferable in some patients.
Nitrous oxide (N,O) (60%) combined with fentanyl (4 pg -kg-' *h-l) decreases the threshold to 34.2 + 0.5"C (16). Similarly, 30% N,O decreases the shivering threshold -1°C (17), thus nearly doubling the normal sweating-to-shivering range (18). However, adding N20 to enflurane decreases the vasoconstriction threshold less than expected (191, suggesting Patients given sevoflurane were then randomly assigned to maintenance anesthesia consisting of: 1) 50% N,O (-0.5 MAC) and 0.5 MAC sevoflurane (1%); or 2) 1.0 MAC sevoflurane (2%) (20,21). Patients given isoflurane were then randomly assigned to maintenance anesthesia consisting of: 1) 60% N,O (eO.5 MAC) and 0.5 MAC isoflurane (0.6%); or 2) 1.0 MAC isoflurane (1.2%) (20, 22) . The concentration of N,O was increased in the second series because there is still some controversy about the MAC of this drug in humans.
Supplemental vecuronium was administered as needed to maintain one to two twitches in response to supramaximal stimulation of the ulnar nerve at the wrist. At least 10 mL * kg-i . h-i fluid was given IV and blood products were replaced to maintain the hematocrit between 25%-32%. Administered fluids were warmed to 37°C.
The patients were covered with a single layer of surgical draping (23); no other warming measures were taken during the study period. Twenty minutes after significant vasoconstriction was observed, patients were actively rewarmed using a forced-air system (Bair Hugger@; Augustine Medical, Inc., Eden Prairie, MN). Subsequent anesthetic management was left to the discretion of the responsible anesthesiologist.
Ambient temperature was measured using a thermocouple positioned at the level of the patient, well away from any heat-producing equipment. Core temperature, before induction of anesthesia, was measured at the tympanic membrane. The aural probe was inserted until the patients felt the thermocouple touch the tympanic membrane; appropriate placement was confirmed when they easily detected a gentle rubbing of the attached wire. The probe was then taped in place, the aural canal occluded with cotton, and the external ear covered with a gauze pad. Tympanic membrane temperatures correlate well with distal esophageal temperatures in the perioperative period (24,25). After induction of anesthesia, core temperature was recorded from the distal esophagus.
Mean skin temperature was calculated from four sites: 0.3&m + Tam) + O.p(Tthigh + Tcaif) (26). Fingertip perfusion was evaluated using forearm minus fingertip skin temperature gradients. Perfusion was recorded from an arm exposed to the operating room environment and not having a blood pressure cuff or IV catheter. There is an excellent correlation between skin temperature gradients and volume plethysmography (27). Temperatures were recorded from Mon-a-Therm@ thermocouples (Mallinckrodt Anesthesia Products, Inc., St. Louis, MO). They were connected to a calibrated Iso-Thermex@ 16-channel electronic thermometer (Columbus Instruments International, Corp., Columbus, OH) having an accuracy of O.l"C and a precision of O.Ol"C.
Heart rate was monitored continuously using threelead electrocardiography.
Blood pressure was determined oscillometrically at 5-min intervals. We used oscillometric rather than direct arterial blood pressure measurements to minimize the artifact induced by thermoregulatory vasoconstriction (28,29). Respiratory gas concentrations were quantified using a calibrated end-tidal gas analyzer (Datex Medical Instrumentation, Inc., Tewksbury, MA). Data were recorded at lo-min intervals, starting immediately before induction of anesthesia ("initial" values). As in previous studies (151, we considered a gradient of 0°C to indicate significant thermoregulatory vasoconstriction.
The distal esophageal temperature triggering significant vasoconstriction was considered the thermoregulatory threshold. The preinduction fluid bolus was not considered part of the intraoperative fluid balance. Fluid administered to the time of vasoconstriction was divided by the time to vasoconstriction to produce the fluid administration rate. Ambient temperature in each case was averaged over time from induction of anesthesia until vasoconstriction.
Morphometric data, initial core temperatures, ambient temperatures, and fluid administration rates in the patients given each volatile anesthetic were compared using Mann-Whitney U-tests. Anesthetic concentrations, vasoconstriction thresholds, core cooling rates, times to constriction, mean skin temperatures, heart rates, and arterial blood pressures at the time of constriction were similarly compared using MannWhitney &tests. All values are expressed as means Values are expressed as means 2 SD; * statistically significant differences between the groups (P < 0.01). MAC = minimum alveolar anesthetic concentration. + SD; differences were considered significant when P < 0.01.
Results
Morphometric characteristics were comparable in the four groups. The initial core temperatures, ambient operating room temperatures, core cooling rates, fluid administration rates, heart rates, and blood pressures did not differ significantly. End-tidal sevoflurane, isoflurane, and N,O concentrations did differ, per protocol (Table 1) .
The threshold for vasoconstriction was 35.8 2 0.3"C in the patients given 50% N20 combined with 0.5 MAC sevoflurane. In contrast, the threshold was 35.1 ? 0.4"C in those given 1.0 MAC sevoflurane. Similarly, the threshold for vasoconstriction was 35.9 + 0.3"C in the patients given 60% N,O combined with 0.5 MAC isoflurane, which was significantly greater than that in those given 1.0 MAC isoflurane: 35.0 2 0.5"C (Fig. 1) . Discussion N,O is known to impair thermoregulatory control in rodents, causing an autonomic (30) and behavioral (31) decrease in core temperature. Similarly, N,O reduces both the vasoconstriction (19) and shivering (17,18) thresholds in humans. However, this report is the first quantifying the relative potency of N,O and a volatile anesthetic. Our results indicate that the vasoconstriction threshold was significantly greater in patients given a combination of N,O and sevoflurane or isoflurane than in those given only sevoflurane or isoflurane, although anesthetic potency was comparable in each of the groups. N20, thus, impairs thermoregulation less than sevoflurane or isoflurane.
Painful stimulation increases the vasoconstriction threshold during enflurane anesthesia (lo), presumably by increasing the activation of the sympathetic nervous system. The observed relatively high vasoconstriction threshold during N,O administration may similarly result from the drug's "sympathetic activation" (32).
Thermoregulatory vasoconstriction, once initiated, is remarkably effective in minimizing further intraoperative core hypothermia (15). [The clinical importance of thermoregulation is illustrated by exaggerated hypothermia when leg vasoconstriction is prevented by combining regional and general anesthesia (33).] Consequently, anesthetics producing relatively little inhibition of thermoregulatory vasoconstriction provide some protection against intraoperative core hypothermia. Our data suggest that combining N,O with volatile anesthetics reduces the vasoconstriction threshold less than a comparable potency of volatile anesthetics alone; this combination may thus be preferable in some patients.
The lower limit of "normothermia" is generally considered to be 36°C. However, core temperatures this low are unusual in unanesthetized individuals, and typically observed-if at all-near 3:00 AM (34). Mean core temperature in humans is near 37"C, and the range of temperatures tolerated without provoking thermoregulatory responses is only 0. with 0.5 MAC sevoflurane or isoflurane reduced the vasoconstriction threshold to <36"C. Clinicians therefore should not depend on thermoregulatory responses alone to prevent intraoperative hypothermia. Instead, patients should be given sufficient passive insulation (23,361 and active warming (13,37,38) to maintain intraoperative core temperatures well above 36°C.
In previous studies we usually considered skin temperature gradients exceeding 4°C as significant vasoconstriction (9-11). We initially chose this value [corresponding to a finger blood flow of -0.2 mL/min (2711 to minimize the chance of inappropriately attributing vasoconstriction resulting from inadequate anesthetic depth or vascular volume depletion to thermoregulation.
However is that thresholds defined in this fashion will be systematically higher than when a more restrictive definition of constriction is used. Consequently, thresholds defined in terms of a 0°C skin temperature gradient should not be directly compared with those defined by other criteria. However, observed differences between the groups in this study remain valid.
A major assumption of this investigation is that the anesthetic potencies of N,O and sevoflurane or isoflurane are additive. Although N,O and three volatile anesthetics were reported to contribute nonlinearly to total MAC in rats (39), the apparent nonadditivity resulted from an incorrect MAC for N,O (40). Current data thus suggest that MAC fractions of N,O and volatile anesthetics are additive.
A second major assumption of this investigation is that the reported anesthetic potencies of N,O, sevoflurane, and isoflurane are accurate. The MAC of N,O in humans remains to be absolutely established. The most commonly cited value is 1.04% (21), although some controversy remains because a suitable test under hyperbaric conditions has yet to be reported. Similarly, the MAC of sevoflurane is generally considered to be 2.0% (20,41), although 1.8% has also been reported (42). The MAC of isoflurane, in contrast, is clearly established at 1.15% (20, 22) . Available data thus suggests that total anesthetic potency was comparable in our four study groups.
Because the results in our first set of patients might have been compromised by uncertainty about the exact MAC values of N20 and sevoflurane, we also evaluated patients given isoflurane where there is no doubt about the MAC. To further assure that our initial conclusions were valid, we used a MAC of N,O equaling 1.2 atm, a value certainly exceeding the actual partial pressure required to prevent movement. Once again, the data indicated that the threshold for vasoconstriction was significantly greater in patients given the combination of N,O and isoflurane than isoflurane alone.
In summary, the threshold for vasoconstriction was 35.8 + 0.3"C in the patients given 50% N,O combined with 0.5 MAC sevoflurane, which was significantly greater than that in those given 1.0 MAC sevoflurane: 35.1 + 0.4"C. Similarly, the threshold for vasoconstriction was 35.9 + 0.3"C in the patients given 60% N,O combined with 0.5 MAC isoflurane, which was significantly greater than that in those given 1.0 MAC 
